PUBLISHER: The Business Research Company | PRODUCT CODE: 1946977
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946977
Pneumothorax treatment devices are medical tools used to manage and treat a collapsed lung, a condition in which air accumulates in the pleural space. These devices aim to remove excess air, restore lung expansion, and prevent further complications, often through methods such as needle decompression or chest tube insertion.
The primary types of pneumothorax treatment devices include ventilator devices, thoracic vent devices, and others. Ventilator devices used in pneumothorax treatment help assist or control breathing by delivering air to the lungs, thereby maintaining oxygen levels and preventing further lung collapse during recovery. These devices are employed in various situations, such as traumatic pneumothorax, spontaneous pneumothorax, and others, in settings such as hospitals, ambulatory surgical centers, and other medical facilities.
Tariffs are impacting the pneumothorax treatment devices market by increasing costs of imported ventilator components, chest drainage systems, and disposable kits. Ventilator devices and thoracic vent segments are most affected, particularly in North America and Europe due to reliance on Asia-Pacific manufacturing. While tariffs have raised procurement costs, they have also encouraged local manufacturing, simplified device designs, and regional sourcing strategies.
The pneumothorax treatment devices market research report is one of a series of new reports from The Business Research Company that provides pneumothorax treatment devices market statistics, including pneumothorax treatment devices industry global market size, regional shares, competitors with a pneumothorax treatment devices market share, detailed pneumothorax treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the pneumothorax treatment devices industry. This pneumothorax treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pneumothorax treatment devices market size has grown rapidly in recent years. It will grow from $3.98 billion in 2025 to $4.39 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to rise in traumatic chest injuries, increased road accident cases, hospital emergency infrastructure growth, adoption of chest tube procedures, critical care unit expansion.
The pneumothorax treatment devices market size is expected to see rapid growth in the next few years. It will grow to $6.43 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to growth in portable emergency devices, advancements in thoracic vent systems, increased ICU admissions, demand for faster lung re-expansion, emergency medical service expansion. Major trends in the forecast period include rapid emergency lung decompression, portable pneumothorax management devices, minimally invasive chest drainage, improved air leak control systems, simplified bedside treatment kits.
The rising number of respiratory diseases is anticipated to drive the growth of the pneumothorax treatment devices market. Respiratory diseases are conditions that affect the lungs and airways, leading to impaired breathing and reduced oxygen exchange. The increase in respiratory diseases is attributed to factors such as air pollution, smoking, viral infections, and greater exposure to allergens. Pneumothorax treatment devices are used in the management of respiratory conditions to treat collapsed lungs and restore normal respiratory function. For example, in September 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, deaths involving influenza rose from 611 in 2023 to 806 in 2024 and further increased to 1,057 deaths in the year to August 2025, representing a 73% rise compared with the same period in 2023. Additionally, deaths involving respiratory syncytial virus (RSV) increased from 380 in 2023 to 468 in 2024 and reached 399 deaths in the year to August 2025. Therefore, the growing incidence of respiratory diseases is driving the expansion of the pneumothorax treatment devices market.
Leading companies in the pneumothorax treatment devices market are focusing on developing advanced technological solutions, such as chest X-ray systems, to maintain their market position. Chest X-ray solutions involve imaging systems and technologies designed to capture detailed radiographic images of the chest, including the lungs, heart, ribs, and surrounding structures. For instance, in September 2023, Qure.ai, a US-based health tech company, announced that it received 510(k) FDA clearance for its innovative chest X-ray solution, qXR-PTX-PE. This solution is specifically designed to aid in the rapid detection of pneumothorax (PTX) and pleural effusion (PE). The AI-powered software enhances care in intensive care units (ICUs) and emergency rooms (ERs) by providing timely notifications to healthcare providers. The qXR-PTX-PE solution analyzes chest X-ray images for critical findings, significantly improving triage efficiency in emergency settings, where these conditions can pose serious risks to patient health.
In June 2023, Merit Medical Systems, Inc., a US-based medical technology company specializing in interventional, diagnostic, and critical care products, acquired AngioDynamics, Inc., for US$100 million in cash. Through this acquisition, Merit Medical aims to reinforce and expand its interventional oncology and lung biopsy-related complication management portfolio by incorporating the BioSentry system, which is designed to reduce the incidence of biopsy-related pneumothorax. This move is intended to strengthen Merit Medical's position in the global pneumothorax treatment devices market while also broadening its offerings in vascular access and dialysis care. AngioDynamics, Inc. is a US-based medical device company focused on minimally invasive vascular, oncology, and biopsy-related products.
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.
North America was the largest region in the pneumothorax treatment devices market in 2025. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pneumothorax treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pneumothorax treatment devices market consists of sales of products including tubes, valves, suction devices and systems, and digital thoracic drainage systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pneumothorax Treatment Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pneumothorax treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pneumothorax treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pneumothorax treatment devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.